Found: 91
Select item for more details and to access through your institution.
Improvements in Tumor Targeting, Survivorship, and Chemoprevention Pioneered by Tamoxifen: A Personal Perspective.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 14, p. 1849
- By:
- Publication type:
- Article
A STAR Is Born.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 9, p. 1126
- By:
- Publication type:
- Article
Improvements in Tumor Targeting, Survivorship, and Chemoprevention Pioneered by Tamoxifen.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 6, p. 553
- By:
- Publication type:
- Article
Chemoprevention of Breast Cancer with Selective Estrogen Receptor Modulators.
- Published in:
- Current Medical Literature: Breast Cancer, 2009, v. 21, n. 3, p. 82
- By:
- Publication type:
- Article
Case history: Tamoxifen: a most unlikely pioneering medicine.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 3, p. 205, doi. 10.1038/nrd1031
- By:
- Publication type:
- Article
Investigation of the mechanism of tamoxifen-stimulated breast tumor growth with nonisomerizable analogues of tamoxifen and metabolites.
- Published in:
- 1993
- By:
- Publication type:
- journal article
High-Dose Oral Tamoxifen, a Potential Multidrug-Resistance-Reversal Agent: Phase I Trial in Combination With Vinblastine.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1992, v. 84, n. 23, p. 1811, doi. 10.1093/jnci/84.23.1811
- By:
- Publication type:
- Article
Growth Regulation of Estrogen Receptor-Negative Breast Cancer Cells Transfected With Complementary DNAs for Estrogen Receptor.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1992, v. 84, n. 8, p. 580, doi. 10.1093/jnci/84.8.580
- By:
- Publication type:
- Article
Overview From the International Conference on Long-Term Tamoxifen Therapy for Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1992, v. 84, n. 4, p. 231, doi. 10.1093/jnci/84.4.231
- By:
- Publication type:
- Article
Alteration of Endocrine Parameters in Premenopausal Women With Breast Cancer During Long-Term Adjuvant Therapy With Tamoxifen as the Single Agent.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1991, v. 83, n. 20, p. 1488, doi. 10.1093/jnci/83.20.1488
- By:
- Publication type:
- Article
Suppression of Mouse Mammary Tumorigenesis by Long-Term Tamoxifen Therapy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1991, v. 83, n. 7, p. 492
- By:
- Publication type:
- Article
Estrogen Receptor-Mediated Direct and Indirect Antitumor Effects of Tamoxifen.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1990, v. 82, n. 21, p. 1662
- By:
- Publication type:
- Article
Effects of Tamoxifen Therapy on Lipid and Lipoprotein Levels in Postmenopausal Patients With Node-Negative Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1990, v. 82, n. 16, p. 1327
- By:
- Publication type:
- Article
Node-Negative Breast Cancer: Tamoxifen and Chemosuppression.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1990, v. 82, n. 12, p. 1068
- By:
- Publication type:
- Article
The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women.
- Published in:
- JAMA: Journal of the American Medical Association, 1999, v. 281, n. 23, p. 2189, doi. 10.1001/jama.281.23.2189
- By:
- Publication type:
- Article
In vitro regulation of vascular endothelial growth factor by estrogens and antiestrogens in estrogen-receptor positive breast cancer.
- Published in:
- Breast Cancer (13406868), 2002, v. 9, n. 1, p. 39, doi. 10.1007/BF02967545
- By:
- Publication type:
- Article
In vitro study of the effect of raloxifene on lipid metabolism compared with tamoxifen.
- Published in:
- European Journal of Endocrinology, 2000, v. 143, n. 3, p. 427, doi. 10.1530/eje.0.1430427
- By:
- Publication type:
- Article
An Overview of Considerations for the Testing of Tamoxifen as a Preventive for Breast Cancer.
- Published in:
- Annals of the New York Academy of Sciences, 1995, v. 768, n. 1, p. 141, doi. 10.1111/j.1749-6632.1995.tb12117.x
- By:
- Publication type:
- Article
A Mutant Receptor as a Mechanism of Drug Resistance to Tamoxifen Treatmenta.
- Published in:
- Annals of the New York Academy of Sciences, 1995, v. 761, n. 1, p. 138, doi. 10.1111/j.1749-6632.1995.tb31375.x
- By:
- Publication type:
- Article
Turning scientific serendipity into discoveries in breast cancer research and treatment: a tale of PhD students and a 50-year roaming tamoxifen team.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 190, n. 1, p. 19, doi. 10.1007/s10549-021-06356-8
- By:
- Publication type:
- Article
ASO Author Reflections: An Optimal Biological Model for Successful Drug Discovery.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 7, p. 1991, doi. 10.1245/s10434-019-07337-4
- By:
- Publication type:
- Article
The SERM Saga, Something from Nothing: American Cancer Society/SSO Basic Science Lecture.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 7, p. 1981, doi. 10.1245/s10434-019-07291-1
- By:
- Publication type:
- Article
Bioluminescence imaging for assessment and normalization in transfected cell arrays.
- Published in:
- Biotechnology & Bioengineering, 2007, v. 98, n. 2, p. 486, doi. 10.1002/bit.21477
- By:
- Publication type:
- Article
Binding of [<sup>3</sup>H] monohydroxytamoxifen in ovarian carcinoma.
- Published in:
- BJOG: An International Journal of Obstetrics & Gynaecology, 1983, v. 90, n. 8, p. 751, doi. 10.1111/j.1471-0528.1983.tb09306.x
- By:
- Publication type:
- Article
Novel agents to modulate oestrogen action.
- Published in:
- British Medical Bulletin, 2000, v. 56, n. 3, p. 773, doi. 10.1258/0007142001903355
- By:
- Publication type:
- Article
Prolactin-Induced Protein (PIP) Regulates Proliferation of Luminal A Type Breast Cancer Cells in an Estrogen-Independent Manner.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0062361
- By:
- Publication type:
- Article
Proteomic Analysis of Pathways Involved in Estrogen- Induced Growth and Apoptosis of Breast Cancer Cells.
- Published in:
- PLoS ONE, 2011, v. 6, n. 6, p. 1, doi. 10.1371/journal.pone.0020410
- By:
- Publication type:
- Article
Tamoxifen for Breast Cancer Prevention.
- Published in:
- Proceedings of the Society for Experimental Biology & Medicine, 1995, v. 208, n. 2, p. 144, doi. 10.3181/00379727-208-43846C
- By:
- Publication type:
- Article
The Search for Antiestrogens.
- Published in:
- 2008
- By:
- Publication type:
- Editorial
Chemoprevention with Antiestrogens: The Beginning of the End for Breast Cancer.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 952, n. 1, p. 60, doi. 10.1111/j.1749-6632.2001.tb02728.x
- By:
- Publication type:
- Article
The Past, Present, and Future of Selective Estrogen Receptor Modulation.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 72, doi. 10.1111/j.1749-6632.2001.tb04004.x
- By:
- Publication type:
- Article
Estrogen Receptors in BRCA1-Mutant Breast Cancer: Now You See Them, Now You Don't.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 22, p. 1655, doi. 10.1093/jnci/djm230
- By:
- Publication type:
- Article
SERMs: Meeting the Promise of Multifunctional Medicines.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 5, p. 350, doi. 10.1093/jnci/djk062
- By:
- Publication type:
- Article
Pak up Your Breast Tumor—and Grow!
- Published in:
- JNCI: Journal of the National Cancer Institute, 2006, v. 98, n. 10, p. 657, doi. 10.1093/jnci/djj204
- By:
- Publication type:
- Article
Intrinsic Mechanism of Estradiol-Induced Apoptosis in Breast Cancer Cells Resistant to Estrogen Deprivation.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 23, p. 1746, doi. 10.1093/jnci/dji400
- By:
- Publication type:
- Article
RESPONSE.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Medroxyprogesterone Acetate and Metastases: Of Mice and (wo)Men.
- Published in:
- 2005
- By:
- Publication type:
- Editorial
RESPONSE.
- Published in:
- 2004
- By:
- Publication type:
- Letter
Apoptotic action of 17beta-estradiol in raloxifene-resistant MCF-7 cells in vitro and in vivo.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Paradoxical action of fulvestrant in estradiol-induced regression of tamoxifen-stimulated breast cancer.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Apoptotic Action of 17β-Estradiol in Raloxifene-Resistance MCF-7 Cells In Vitro and In Vivo.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2003, v. 95, n. 21, p. 1586, doi. 10.1093/jnci/djg080
- By:
- Publication type:
- Article
Re: Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999.
- Published in:
- 2003
- By:
- Publication type:
- Letter
Is tamoxifen the Rosetta stone for breast cancer?
- Published in:
- 2003
- By:
- Publication type:
- Editorial
Effects of raloxifene after tamoxifen on breast and endometrial tumor growth in athymic mice.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Selective Estrogen Receptor Modulation and Reduction in Risk of Breast Cancer, Osteoporosis, and Coronary Heart Disease.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2001, v. 93, n. 19, p. 1449, doi. 10.1093/jnci/93.19.1449
- By:
- Publication type:
- Article
How is tamoxifen's action subverted?
- Published in:
- 2000
- By:
- Publication type:
- Editorial
Correspondence.
- Published in:
- 1999
- By:
- Publication type:
- Letter
Tamoxifen: The herald of a new era of preventive therapeutics.
- Published in:
- 1997
- By:
- Publication type:
- Editorial
Proven value of translational research with appropriate animal models to advance breast cancer treatment and save lives: the tamoxifen tale.
- Published in:
- British Journal of Clinical Pharmacology, 2015, v. 79, n. 2, p. 254, doi. 10.1111/bcp.12440
- By:
- Publication type:
- Article
Correction to: Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article